OncologyTube Professional - Patients Click Here
1,510,672 video views
Loading........
Description: Recent approvals in hepatocellular carcinoma (HCC) have increased the treatment options available for patients with this disease, leading to improved clinical outcomes. However, there is no single tre...
55:22
Recent approvals in hepatocellular carcinoma (HCC) have increased the treatment options available for patients with this disease, leading to improved clinical outcomes. However, there is no single treatment strategy that can be applied to all patients with HCC. Hence, it creates an unmet educational...
by:imedex | 19 views
09:01
In this Virtual Patient Case, renown clinical expert Dr. Martyn Caplin utilizes a follow-up clinical scenario to elucidate the latest advances and insights from pivotal clinical trials on carcinoid syndrome. Earn CME credit for a related activity at the following location: http://elc.i......
by:imedex | 78 views
10:00
In this Virtual Patient Case, renown clinical expert Dr. Martyn Caplin utilizes a clinical scenario to elucidate the latest advances and insights from pivotal clinical trials on carcinoid syndrome. Earn CME credit for a related activity at the following location: http://elc.i......
by:imedex | 49 views
02:21
In this whiteboard video, Dr. John N. Allan of Weill Cornell Medicine discusses the mechanisms of action of anti-apoptotic BCL2 inhibitors. Earn CME credit for a related activity at the following location: http://elc.i... © 2018 Imedex, LLC.
by:imedex | 84 views
02:19
In this whiteboard video, Dr. John N. Allan of Weill Cornell Medicine discusses the mechanisms of action of anti-CD20 agents. Earn CME credit for a related activity at the following location: http://elc.i... © 2018 Imedex, LLC.
by:imedex | 91 views
06:29
In this whiteboard video, Dr. John N. Allan of Weill Cornell Medicine discusses the mechanisms of action of BRC signaling inhibitors. Earn CME credit for a related activity at the following location: http://elc.i... © 2018 Imedex, LLC.
by:imedex | 77 views
23:24
Dramatic progress has been made in our understanding of the clinical, biological and molecular heterogeneity of chronic lymphocytic leukemia (CLL). Despite this, treatment challenges remain, particularly in patients with high-risk disease. This Velocity Vlog activity featuring Dr. John N. Allan addr...
by:imedex | 552 views
08:02
Co-chair Dr. John P. Leonard summarizing the key take-home points presented during the Lymphoma session at this year’s Great Debates & Updates in Hematologic Malignancies conference. Earn CME Credit for this activity: http://elc.i... © 2018 Imedex, LLC.
by:imedex | 460 views
07:46
Co-chair Dr. David P. Steensma summarizes the key take-home points presented during the sessions on leukemia, benign hematology, and myeloid disorders at this year’s Great Debates & Updates in Hematologic Malignancies conference. Earn CME Credit for this activity: http://elc.i......
by:imedex | 463 views
07:03
Guest faculty Dr. Paul G. Richardson summarizes the key take-home points from the presentations comprising this year’s Plasma Cell Disorders session at the 2018 Great Debates & Updates in Hematologic Malignancies conference. Earn CME Credit for this activity: http://elc.i... © 2018 Imedex, LLC.
by:imedex | 439 views

About imedex
Description: Imedex® has provided the best in accredited, independent continuing medical education for over 25 years. We develop high quality, scientific programs that translate the latest research into clinically relevant information. The programs have a proven sustained impact on disease management, exceptional organization, and outstanding educational value. Imedex is an industry leader in providing accredited, independent continuing medical education to health care professionals. We develop high quality, scientific programming that translates the latest research into clinically relevant information. The activities have exceptional organization and outstanding educational value, with a proven sustained impact on disease management. Our programs focus on improving patient care around the world. With over 50,000 e-learning experiences annually and more than 102,000 live meeting attendees since 2001, Imedex truly educates the global healthcare community. At Imedex, we believe that education is the best medicine.

Links
Channel Url:

Social Links: